curriculum vitae revised 9/31/98parathyroid.surgerymountsinai.org/wp-content/uploads/si… · web...

CURRICULUM VITAE Revised 12/2014

Sherif I. Heiba, M.D.

ACADEMIC APPOINTMENTS

3/06 till present Associate Professor of Radiology Mount Sinai School of MedicineNew York, NY

10/03 – 2/06 Associate Professor of Radiology New York Medical CollegeNew York, NY

7/99 – 9/03 Assistant Professor of Radiology New York Medical CollegeNew York, NY

1/95 –6/99 Assistant Professor, Department of Nuclear MedicineFaculty of MedicineKuwait University

7/93 – 12/94 Instructor, Division of Nuclear MedicineUniversity of Washington School of MedicineSeattle, Washington

HOSPITAL APPOINTMENTS

3/06 till present Attending Physician, Department of RadiologyMount Sinai Medical CenterNew York, NY

7/99 – 2/06 Assistant Director, Nuclear Medicine Division,Department of RadiologySaint Vincent’s Hospital and Medical CenterNew York, NY

1/95 – 6/99 Consultant and Vice Chairman,Nuclear Medicine DepartmentMubarak Al-Kabeer HospitalKuwait City, Kuwait

7/93 –12/94 Assistant Director, Research Radionuclide Laboratory,

1

Attending Physician,Division of Nuclear MedicineVeterans Administration Medical CenterSeattle, Washington

7-12/1990 Admitting Physician of Ambulatory Care. Veterans Administration Medical Center - Tucson, Arizona.

DEPARTMENTAL RESPONSIBILITIES

3/06 till Present Director, Nuclear Medicine Residency Program,Department of RadiologyMount Sinai School of MedicineNew York, NY

EDUCATION

9/71 – 1/78 Medical School, Alexandria University Faculty of MedicineAlexandria, Egypt

POSTGRADUATE TRAINING

1991 - 1993 Fellow - Nuclear Cardiology/Nuclear Medicine. University of Washington Medical Center - Seattle, Washington

1988 -1991 Resident - Internal Medicine. University of Arizona Health Sciences Center - Tucson, Arizona

1986 - 1988 Resident - Nuclear Medicine. University of Miami/Jackson Memorial Hospital - Miami, Florida

CERTIFICATIONS

2011 Recertification, American Board of Nuclear Medicine # 05746

2002 Recertification, American Board of Nuclear Medicine # 05746

2000 Diplomat, Certification Board of Nuclear Cardiology # 1708

1992 Diplomat, American Board of Nuclear Medicine # 05746

1991 Diplomat, American Board of Internal Medicine # 135616

2

1989 Federation Licensing Examination (FLEX)

1983 Education Commission for Foreign Medical Graduates (ECFMG) Certification #335-023-8

1982 Visa Qualifying Examination (VQE)

1978 Medical Diploma (M.B., Ch.B.)

LICENSURE

2008 Pennsylvania # MD434154

1999 New York # 213637

1996 California # A060904

1991 Washington # 28517

1990 Arizona # 19320

1989 Florida # 55103

HONORS

Asa E. Seeds Award of Nuclear Medicine, Washington 1993

Chief Resident of Nuclear Medicine University of Miami/JacksonMemorial Medical Center; July 1987 - June 1988

Graduated from Medical School in Top 10%

Graduated from High School with honors; 7th in Nation

PROFESSIONAL SOCIETIES

Society of Nuclear Medicine

American Society of Nuclear Cardiology

American College of Physicians

3

American College of Nuclear Physicians

American Medical Association

GRANTS AND CONTRACT SUPPORT

PREVIOUS GRANT AND CONTRACT SUPPORT

List Funding Source, Project Title & Number

Role in Project Dates Direct Costs Supplemental Info

Funding Source: King Pharmaceuticals Research and Development, Inc

Study Title: Randomized, single blinded, two-arm crossover, dose-selection study of MRE0470 as an adjunct to myocardial perfusion imaging

Role: Co-Investigator

PI:James E. Udelson, MD

2001-2002



Funding Source: King Pharmaceuticals Research and Development, Inc.

Study Title: Vasodilator Induced Stress In CONcordance with Adenosine(VISION-301)


PI: James E. Udelson, MD

2002– 2003


Role in Project

Dates Direct Costs Supplemental Info

Funding Source: Bristol-Myers Squibb Medical Imaging, Inc

Study Title: Low dose dobutamine Nitrate-Enhanced Rest/Stress Tc-99m Sestamibi Protocol (CG# 23019)

Role: Principle Investigator

2003– 2005



Funding Source: Blood and Cancer Research Fund, New York, NY.


2007-2010

4

Study Title: Evaluation of therapy response using FDG PET/CT in patients with multiplemyeloma undergoing bone marrow transplantation

GCO# 08-0013

PI: Lale Kostakoglu, M.D.

Mount Sinai Medical CenterNew York, NY



Funding Source: Mount Sinai School Of Medicine.

Study Title: A Combined Evaluation Strategy of F-18 FDG PET/CT and Contrast-Enhanced Diagnostic CT for Lymph Nodes in the Neck

GCO# 11-0189-00001-01-PD




2010-2011

CURRENT GRANT AND CONTRACT SUPPORT


Role in Project Dates Direct Costs

Supplemental Info

Funding Source: Mount Sinai School Of Medicine

Study Title: An evaluation of the utility of dual-isotope SPECT/CT for localizing infections in the diabetic foot

GCO# 09-0691-00001-04-PD

Role: Principal InvestigatorSherif Heiba, M.D.Mount Sinai Medical CenterNew York, NY

2008-2012



Supplemental Info

Funding Source: Mount Sinai School Of Medicine

Study Title: The incremental value of SPECT/CT Imaging to thyroid gland/dual phase Sestamibi pinhole imaging in the evaluation of primary hyperparathyroidism Patients.

GCO# 09-1805-00001-04-PD

Role: Principal InvestigatorSherif Heiba, M.D.Mount Sinai Medical CenterNew York, NY

2009-2012



Supplemental Info

Funding Source: Surefire Medical, Role: Co- 2012-2013

5

Inc.

Study Title: Coiling the GDA vs. Surefire During Y90 Infusion: The COSY Trial

GCO#

Investigator

PI: AARON M FISCHMAN, M.D.




Supplemental Info

Funding Source: Nordion

Study Title: Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy

GCO# 12-1658-00001-01-PD


PI: RANDALL F HOLCOMBE, M.D.


2012-2013



Supplemental Info

Funding Source: Aposense.

Study Title: A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of (18F)-ML-10, a PET Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy

GCO# 10-0926-00001-03-PD




2012-2013



Supplemental Info


Study Title: PET/CT imaging for the assessment of bio-distribution of yttrium-90 (Y-90) in patients with unresectable hepatic tumors who have received intra arterial radioembolization therapy with Y-90 microspheres

GCO# 12-0560-00001-01-PD


PI: JOSEF MACHAC, M.D.


2012-2013

List Funding Source, Project Role in Project Dates Direct

CostsSupplemental Info

6

Title & Number

Funding Source: Medivation.

Study Title: PREVAIL: A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naive Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy

GCO# 10-1535-00001-02-PD


PI: Simon J Hall, M.D.


2010-2012



Supplemental Info


Study Title: 4-Dimensional CT scanning versus conventional Sestamibi scanning or CT scanning for the localization of hyperfunctioning parathyroid glands

GCO# 10-1103-00001-02-PD


PI: Randall P Owen, M.D.


2009-2012

TEACHING ACTIVITIES

TEACHING ACTIVITY/ TOPIC

LEVEL ROLE NUMBER OF LEARNERS

NUMBER OF HOURS PER WEEK/MONTH/YEAR

YEARS TAUGHT

Nuclear Cardiology Training of Cardiology Fellows

Divisions of Nuclear Medicine and Cardiology, University of Washington

Instructor 30 6 hr/yr 1993-1994

Conferences to Radiology and Nuclear Medicine Residents

Division of Nuclear Medicine,University of Washington

Instructor 25 5 hrs/yr 1993-1994

Nuclear Cardiology Course for Medical Students

University of Washington School of Medicine Course

Instructor 40 4 hr/yr 1993-1994

Medical Students Nuclear Medicine Introduction Course

Kuwait University, Faculty of MedicineCourse

Teaching/Attending

30 6 hrs/yr 1995 – 1999

Medical Students Surgical/Nuclear Medicine Seminars

Kuwait University, Faculty of Medicine Course

Teaching/Attending

30 5 hrs/yr 1996 – 1999

nuclear cardiology in

Kuwait University, Faculty of Medicine

Teaching/Attending

10 5 hrs/yr 1997 – 1999

7

postgraduatecardiology programTutorial lecturesfor radiology and nuclear medicine residents

Departmentof Radiology,New York Medical College

Teaching/Attending

20 6 hrs/yr 1999-2005

Case conferenceFor nuclear medicine residents

Division of Nuclear Medicine, New York Medical College

Teaching/Attending

3 1 hr/mo 1999-2005

Nuclear Cardiology lectures for Cardiology fellows

Division of Cardiology,New York Medical College

Teaching 20 4 hrs/yr 2001-2005

General PET/CT sessions

Division of Nuclear Medicine

Attending 2 3 hr/wk 2006-2014

General Nuclear Medicine sessions


Attending 3 6 hr/wk 2006-2014

Grand Rounds,Radionuclide Investigations of the Urinary Tract

Department ofUrology

Teaching/Attending

40 1 hr 2007

Medical Grand Rounds

Department ofMedicine, Division of Pediatric Nephrology

Teaching/Attending

7 1 hr 2007

Journal Club Division of Nuclear Medicine

Attending 12 4 hr/yr 2006-2014

Grand Rounds Division of Nuclear Medicine

Teaching/Attending

12 2 hr/yr 2006-2014

Case conferenceFor nuclear medicine residents


Teaching/Attending

5 1 hr/mo 2006-2012

Boards Reviewfor radiology residents

Departmentof Radiology

Teaching/Attending

9 2 hr/yr 2006-2012

Tutorial lecturesfor radiology and nuclear medicine residents

Departmentof Radiology

Teaching/Attending

18 12 hr/yr 2006-2014

Research conferences


Teaching/Attending

12 2 hr/yr 2006-2014

Nuclear Medicine tutorial to medical students in anatomic radiology clerkship

Mount Sinai School of Medicine Course

Teaching/Attending

30 6 hrs/yr 2006-2008

Nuclear Medicine tutorial to medical students in anatomic radiology clerkship

Mount Sinai School of Medicine Course

Teaching/Attending

20 3 hrs/yr 2009-2014

Nuclear Medicine Residency Program

Mount Sinai School of Medicine,Post graduate

Director 4 8 hrs/wk 2006-2014

8

Program

PUBLICATIONS

Peer Reviewed Original Articles

Heiba S, Jiang M, Rivera J, Genden E, Inabnet III W, Machac J, Kostakoglu L. Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clin Nucl Med. Revision under review. 2015.

Heiba, S, Kolker, D, Ong, L, Sharma, S, Travis, A, Teodorescu, V, Ellozy, S, Kostakoglu, L, Savitch, I, Machac, J. Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources. Nucl Med Commun. 2013;34:877-884.

Jiang M, Fischman A, Nowakowski SF, Heiba S, Zhang Z, Knesaurek K, Weintraub J and Machac J. Segmental perfusion differences on paired Tc-99m macroaggregated albumin hepatic perfusion imaging and yttrium-90 bremsstrahlung imaging studies in SIR-Sphere radioembolization:Associations with angiography. J Nucl Med Radiat Ther. 2012;3:1-5.

Jiang M, Nowakowski FS, Wang J, Heiba S, Zhang Z, Weintraub J, Kim E, Machac J. Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy. Cancer Biotherapy & Radiopharmaceuticals 2011, 26: 511-518.

Heiba SI, Kolker D, Mocherla B, Kapoor K, Jiang M, Son H, Rangaswamy B, Kostakoglu L, Savitch I, DaCosta M, Machac M. The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg 2010;49:529-36.

Knešaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, Heiba S. Quantitative Comparison of yttrium-90 (90Y)-microspheres and Technetium-99m (99mTc)-macroaggregated Albumin SPECT Images for Planning 90Y Therapy of Liver Cancer. Tech Cancer Res Treat 2010;9:253-261.

Heiba SI, Raphael B, Castellon I, Altinyay E, Sandella N, Rosen G, Abdel-Dayem HM. PET/CT image fusion error due to urinary bladder filling changes: consequence and correction. Ann Nucl Med 2009;23:739-744.

Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected

9

primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med 2009;50:1448-1454.

Vik TA, Pfluger T, Kadota R, Castel V, Tulchinsky M, Farto JC, Heiba S, Serafini A, Tumeh S, Khutoryansky N, Jacobson AF. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer 2009;52:784-790.

Heiba SI, Yee G, Abdel-Dayem HM, Youssef I, Coppola J. Combined rest redistribution thallium-201 SPECT and low-dose dobutamine contractility assessment in a simple and practical new viability protocol. Ann Nucl Med. 2009;23:197-203.

Berson AM, Stein NF, Riegel AC, Destian S, Ng T, Tena LB, Mitnick RJ and Heiba SI. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, part II: The impact of a contouring protocol. Med Dosim. 2009;34:30-35.

Piperkova E, Raphael B, Altinyay ME, Castellon I, Libes R, Sandella N, Heiba S, Abdel-Dayem H. Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management. Clin Nucl Med 2007;32:429-434.

Elgazzar AH, Loutfi I, Baqer M, Farghali M, Khadada M, Heiba S, Uza O, Mahussein S, Al-Tailji S. Post-test probability for pulmonary embolism after ventilation-perfusion scan assessed by nuclear medicine physicians.Med Princ Pract 2005;14:217-220

Heiba SI, Abdel-Dayem HA, Gould R, Bernaski E, Morlote M, El-Zeftawy H and Ambrose JA. Value of low dose dobutamine addition to routine dual isotope gated SPECT myocardial imaging in patients with healed myocardial infarction or abnormal wall thickening by echocardiogram. Am J Cardiol 2004;93:300-306.

Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernick S, Mills C, Wallack M, Abdel-Dayem HM. Retrospective analysis of sentinel node localization in multicenteric palpable and non-palpable breast cancer. J Nucl Med 2003;44:7-10.

Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Dede F and Abdel-Dayem HM Transient post-ischemic stunning evaluation by gated SPECT thallium-201 stress myocardial imaging: effect on systolic LV function. J Nucl Cardiol 2002;9:482-490.

Santiago J, Heiba SI, Jana S, Mirzaitehrane M, Dede F and Abdel-Dayem HM Transient ischemic stunning of the myocardium in stress thallium-201 gated SPET perfusion imaging: Segmental analysis of myocardial perfusion, wall motion and wall thickening changes. Eur J Nucl Med 2002;29:979-983.

10

El-Zeftawy H, Heiba SI, Jana S, Rosen G, Salem S, Santiago SF, and Abdel-Dayem HM. Role of repeated F-18 Fluorodeoxyglucose imaging in the management of patients with bone and soft tissue sarcoma. Cancer Biotherap Radiopharm 2001;16:37-45.

Higazzy E, Al-Saeedi F, Loutfi I, Heiba S, Kalaoui M, Al-Nakib B, et al. The impact of brushing teeth on Carbon-14 urea breath test results. J Nucl Med Technol 2000;28:162-164.

Heiba SI, Jacobson AF, Cerqueira MD, Shattuc S and Sharma S. The additive values of radionuclide ventriculography and extent of myocardium at risk to dipyridamole thallium-201 imaging for optimal risk stratification prior to vascular surgery. Nucl Med Commun 1999;20: 887-894.

Heiba SI, Ziada G, Higazy E and Saleh M. Assessment of Tc-99m tetrofosmin lung uptake: A modified method to avoid the contribution from high chest wall activity. Nucl Med Commun 1998;9:859-866.

Heiba SI, Cerqueira MD and Jacobson AF and Ferreira MJ. The Value and Correlates of Left Ventricular Cavity Assessment in Dipyridamole 201Tl SPET Studies. Nucl Med Commun 1998;19:443-449.

Heiba SI, Hayat N J, Salman HS, Higazy E, Sayed ME, Saleh Z, Khalaf AI, Naeem M and Bourosly S. Tc-99m MIBI myocardial SPECT: supine versus right lateral imaging and comparison with coronary arteriography. J Nucl Med 1997;38:1510-1514.

Serafini A, Jeffers L, Reddy R, Heiba S, Schiff E. Early recognition of recurrent hepatocellular carcinoma utilizing Gallium-67 citrate scintigraphy. J Nucl Med 1988;29:712-716.

Other Peer Reviewed Publications

Sideras PA, Patil V, Li Z, Heiba S, Lale Kostakoglou L. PET–CT of mesenteric panniculitis: A potential confounder of lymphoma. Radiography 2015; 21:51-53.

Sideras PA, Heiba S, Machac J, Hechtman J, Vatti S. Mycobacterial pseudotumor of the plantar fascia: how common is it? Clin Imaging. 2013;37:802-805.

Gallagher EJ, Courgi R, Heiba S, Tamler R. Resolution of insulin-requiring diabetes in a liver transplant recipient after treatment of a pheochromocytoma: case report and review of literature. Minerva Endocrinol. 2011;36:341-345.

11

Jiang M, Gandikota N, Ames S, Heiba S. Identification of Urologic Complications after Kidney Transplant. Am J Kidney Dis 2011;58:150-153.

Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L, Machac J, Heiba S and Kostakoglu L. Role of FDG PET/CT in Staging of Recurrent Ovarian Cancer. RadioGraphics 2011;31:569–583.

Son H, Heiba S, Kostakoglu L, Machac J. Extraperitoneal urine leak after renal transplantation: the role of radionuclide imaging and the value of accompanying SPECT/CT - a case report. BMC Medical Imaging 2010,10:23;1-5.

Son H, Kositwattanarerk A, Hayes MP, Chuang L, Rahaman J, Heiba S, Machac J, Zakashansky K, Kostakoglu L. PET/CT evaluation of cervical cancer: spectrum of disease. Radiographics 2010;30:1251-68.

Cholewinski W, Castellon I, Raphael B, Heiba SI. Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT. Clin Nucl Med. 2009;34:1-3.

Heiba SI, Bernik S, Raphael B, Sandella N, Cholewinski W, and Klein P. PET/CT distinctive role in breast carcinoma staging in the presence of brown fat adipose tissue FDG uptake. Breast J 2005;11:457-461.

Katzel JA, Heiba SI. PET/CT F-18 FDG Scan Accurately Identifies Osteoporotic Fractures in a Patient with Known Metastatic Colorectal Cancer. Clin Nucl Med 2005;30:651-654.

Youssef IM, Milardovic R, Perone RW, Heiba SI, Abdel-Dayem HM. Importance of Tc-99m sulfur colloid liver spleen scan performed before indium-111 labeled leukocyte imaging for localization of abdominal infection. Clin Nucl Med 2005;30:87-90.

Sood A, Youssef IM, Heiba SI, El-Zeftawy H, Axelrod D, Seigel B, Mills C, Abdel-Dayem HM. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med 2004;29:698-702.

Williams ST, Heiba SI, Whooley BP, Ciavarra GA and Abdel-Dayem HA. Postchemoembolization liver abscess: Findings on hepatobiliary scintigraphy. Clin Nucl Med 2002;27:179-182.

Dede F, Ajoedi NDY, Ansari SM, Jana S, Heiba SI and Abdel-Dayem HA. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography. Clin Nucl Med 2001;26:396-399.

Ansari SM, Heiba SI, Mills C, Abdel-Dayem HM. Localization of breast sentinel node after axillary node dissection with diversion of lymphatic drainage to internal

12

mammary lymph nodes and the importance of delayed imaging. Clin Nucl Med 2001;26:647-648.

Heiba SI, Luo JQ, Sadek S, Macalental E, Cacavio A, Rosen G and Abdel-Dayem HA. Attenuation-correction induced artifact in F-18 FDG imaging following total knee replacement. Clin Pos Imag 2000;3:237-239.

Buyukdereli G, Heiba S, Salem S, Santiago J, Goswami G, Jana S and Abdel-Dayem H. Tc-99m MAG3 scintigraphy in unusually dilated bilateral external pelves. Clin Nucl Med 2000;25:471-472.

Goswami GS, Jana S, Santiago S, Buyukdereli G, Salem S, Heiba S and Abdel-Dayem HM. Discrepancy between Ga-67 citrate and F-18 FDG PET scans in pulmonary infection. Clin Nucl Med 2000;25:490-491.

Heiba SI, Salem S, Jana S, et al: The utility of F-18 FDG imaging in the routine evaluation of patients with Sarcoidosis: Preliminary report. Clin Nucl Med 2000; 25:327.

Salem S, Heiba S, Jana S, Santiago S and Abdel-Dayem HM. Unusual presentation of solitary bone metastasis from breast carcinoma mimicking acute osteomyelitis of mid-tibial shaft. Clin Nucl Med 2000;25:480-481.

Book Chapters

Sherif Heiba. Nuclear Medicine Bone Cases. In: Chun K Kim, ed. Nuclear Medicine Volume, Cases in Radiology. London. Oxford University Press, in press.

Sherif I Heiba and Mohammad Zubaid. Basis of Cardiac Imaging: Myocardial contractility and assessment of cardiac function. In: Elgazzar AH, ed. The Pathological Basis of Nuclear Medicine, Third Edition. Berlin: Spinger-Verlag, 2014.

Sherif I Heiba and Mohammad Zubaid. Basis of Cardiac Imaging 1:Myocardial contractility and assessment of cardiac function. In: Elgazzar AH, ed. The Pathological Basis of Nuclear Medicine, Second Edition. Berlin: Spinger-Verlag, 2006.

Heiba SI and Zubaid M. Myocardial contractility and assessment of cardiac function. In: Elgazzar AH, ed. The Pathological Basis of Nuclear Medicine. Berlin: Spinger-Verlag, 2001.

Abdel-Dayem HM, Luo J, Sadek S, Salem S, Santiago J, Jana S, El-Zeftawy H and Heiba S. Multifunctional gamma camera coincidence imaging, current status and

13

evaluation of clinical results. In. Freeman L, ed. Nuclear Medicine Annual 2000. Philadelphia: Lippincott Williams & Wilkins, 2000.

Heiba SI and Cerqueira MD. Evaluation of cardiac function. In: Cerqueira MD, ed. Nuclear Cardiology. Massachusetts: Blackwell Scientific, 1994.

Abstracts

Knesaurek K, Eldib M, Bini J, Kim E, Heiba S, Fayad Z, Kostakoglu L. PET/MRI and PET/CT imaging in liver selective internal radiation therapy with Y-90 microspheres. Which approach is better? Eur J Nucl Med Mol Imaging 2014; 41:S255.

Heiba S, Stempler L, Machac J, Kostakoglu L. The utility of dual isotope SPECT/CT imaging in patient with infected pelvic pressure ulcer & suspected osteomyelitis. J. Nucl Med 2014; 55:1972.

Zhang Z, Stempler L, Knesaurek K, Heiba S, Zaretsky V, Mihaila A. Assessment of overall survival: Y-90 microspheres treatment of unresectable hepatocellular carcinoma J. Nucl Med 2014; 55: 209.

Knesaurek K, Eldib M, Zhang Z, Bini J, Banibaker K, Rodriguez E, Kim E, Heiba S, Fayad Z, Kostakoglu L. Comparison of PET/MRI and PET/CT studies in liver selective internal radiation therapy with 90Y microspheres. J. Nucl Med 2014; 55: 1450.

Heiba S, Sideras P, Kostakoglu L, Savitch I, Machac J. The early distinction between diabetic foot osteomyelitis and Charcot joint during initial phase leukocyte (WBC)/bone scan dual isotope SPECT/CT imaging. J. Nucl. Med 2013; 54: 654.

Sosa N, Marshall R, Corcuera-Solano I, Knight-Greenfield A, Stern J, Machac J, Heiba S, Kostakoglu L. Lymph node measurements based on low dose FDG-PET/CT appear equivalent to those obtained by contrast-enhanced CT in Hodgkin lymphoma. J. Nucl. Med 2013; 54: 1565.

Zhang Z, Fardanesh R, Machac J, Heiba S, Knesaurek K, Zaretsky V, Mihaila A, Nowakowski S, Fischman A, Kim E. Comparison of therapeutic response using RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable hepatocellular carcinoma. J. Nucl. Med 2013; 54: 224.

Heiba S, Kolker D, Sharma S, Travis A, Teodorescu V, Ellozy S, Kostakoglu L, Savitch I, Machac J. Impact of dual isotope SPECT/CT on hospitalized patients

14

with suspected diabetic foot infection: Comparison to conventional imaging. J Nucl Med 2012; 53:542.

Fardanesh MR, Gandikota N, Chari A, Jagannath S, Machac J, Heiba S, Kostakoglu L. FDG PET/CT imaging characteristics in multiple myeloma patients at staging and follow-up. J Nucl Med 2012; 53:1056.

Zhang Z, Machac J, Heiba S, Knesaurek K, Zaretsky V, Mihaila A, Weintraub J, Nowakowski S, Kim E. Comparison study of the treatment of unresectable hepatocellular carcinoma with Y-90 SIR-Spheres and Y-90 TheraSphere. J Nucl Med 2012; 53:1201.

Heiba S, Kolker D, Ong L, Khan K, Teodorescu V, Ellozy S, Novruzov F, Kostakoglu L, Savitch I, and Machac J. The beneficial influence of dual isotope SPECT/CT use on management of patients with suspected diabetic foot infection. J Nucl Med 2011;52:14P. Heiba S, Jiang M, Rivera J, Son H, Genden E, Weber K, Inabnet W, Kostakoglu L, Savitch I, Machac J. Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies with & without SPECT/CT for parathyroid adenoma localization. J Nucl Med 2011;52:72P. Jiang M, Nowakowski FS, Fischman A, Heiba S, Zhang Z, Weintraub J, Machac J. Segmental perfusion differences on paired Tc-99m MAA hepatic perfusion imaging and Yttrium-90 microsphere imaging: Associations with angiography.J Nucl Med 2011;52:88P. Gandikota N, Ng SA, Cotter R, Peti S, Heiba S, Machac J, Genden E, Som P, Kostakoglu L. A combined evaluation strategy of FDG PET/CT and contrast enhanced diagnostic CT (ceCT) for cervical lymph nodes. J Nucl Med 2011;52:98P. Gandikota N, Simpson W, Peti S, Roayaie S, Heiba S, Machac J, Labow D, Kostakoglu L. Performance of FDG-PET/CT and contrast enhanced MRI in the evaluation of hepatic metastasis of gastrointestinal malignancies. J Nucl Med 2011;52:1822P. Moonthungal S, Heiba S, Gandikota N, Kostakoglu L, Savitch I, Machac J. Additive value of dual-time point SPECT/CT to routine planar octreotide scans. J Nucl Med 2011;52:219P. Khan S, Mendelson D, Peti S, Heiba S, Savitch I, Machac J, Kostakoglu L. Solitary pulmonary nodules characterized by FDG-PET/CT and high resolution chest CT. J Nucl Med 2011;52:487P.

15

Heiba S, Stock J, Khan S, Rosenberg H, Kostakoglu L, Savitch I and Machac J. Advantage of SPECT/CT use in DMSA renal imaging for work-up of suspected acute pyelonephritis. J Nucl Med. 2010; 51 (Supplement 2):425

Jiang M, Khan S, Genden E, Heiba S, Machac J and Kostakoglu L. Comparison of FDG-PET/CT and contrast enhanced CT in detection of locoregional recurrence in thyroid cancer patients. J Nucl Med. 2010; 51 (Supplement 2):463

Heiba S, Jiang M, Kostakoglu L, Savitch I and Machac J. Superiority of SPECT/CT over SPECT & planar I-123 MIBG in workup of patients with known or suspected pheochromocytoma. J Nucl Med. 2010; 51 (Supplement 2):1560

Khan S, Jiang M, Rahaman J, Hayes M, Machac J, Heiba S and KostakogluL. The role of FDG PET/CT imaging in detection of recurrent ovarian cancer. J Nucl Med. 2010; 51 (Supplement 2):1091

Zhang Z, Jiang M, Machac J, Heiba S, Lipszyc H, Zaretsky V, Knesaurek K, Warner R, Weintraub J and Nowakowski S. Y-90 SIR-Sphere treatment of unresectable liver cancers. J Nucl Med. 2010; 51 (Supplement 2):333

Heiba S, Rivera J, Jiang M, Genden E, Esfahane A, Weber K, Rivera M, Kostakoglu L, Savitch I and Machac J. The optimized evaluation of primary hyperparathyroid patients with dual tracer neck pinhole and SPECT/CT imaging. J Nucl Med. 2010; 51 (Supplement 2):1573

Heiba S, Kolker D, Ong L, Khan S, Jiang M, Teodorescu V, Ellozy S, Kostakoglu L, Savitch I and Machac J. The continuing management of diabetic foot infection: Impact of follow-up with dual tracer SPECT/CT. J Nucl Med. 2010; 51 (Supplement 2):370

Jiang M, Machac J, Zhang Z, Heiba S, Knesaurek K, Stangl A and Weintraub J. Deposition of Yttrium-90 microspheres in the gastroduodenum is associated with early stasis/reflux and likely caused by reflux to the gastroduodenal artery. J Nucl Med. 2010; 51 (Supplement 2):1162

Knesaurek K, Kolker D, Vatti S, Machac J, Kostakoglu L, Muzinic M, DaCosta M, Son H, Kapoor K and Heiba S. Precise fusion of MRI and dual energy In-111 WBC/Tc-99m HDP SPECT/CT in diabetic foot using companion CT. J Nucl Med 2009; 50:1365P

Zhang Z, Machac J, Heiba S, Jiang M, Lipszyc H, Zaretsky V, Knesaurek K, Warner R, Weintraub J, Nowakowski S, Stangl A, Schwartz M, Labow D, Roayaie S and Sung M. Y-90 SIR-Sphere treatment of unresectable primary or metastatic liver tumors. J Nucl Med 2009; 50:161P

16

Kapoor K, Lo Y, Mendelson D, Heiba S, Machac J and Kostakoglu L. Combination of PET/CT and high resolution chest CT (HRCT) for characterizing pulmonary nodules. J Nucl Med 2009; 50:1792P

Heiba S, Jiang M, Weintraub J, Nowakowski S, Stangl A, Nowakowski S, Kim E, Knesaurek K, Zhang Z and Machac J. The effectiveness of SPECT/CT in hepatic arterial Tc-99m MAA scan (MAAS) planning prior to hepatic Y-90 microsphere therapy (YT). J Nucl Med 2009; 50:1663P

Kapoor K, Peti S, Simpson W, Heiba S, Machac J and Kostakoglu L. Review of PET-CT findings in patients with suspected recurrence of pancreatic and cholangiocarcinoma. J Nucl Med 2009; 50:1103P

Kapoor K, Kostakoglu L, Knesaurek K, Savitch I, Machac J and Heiba S. Advances in the diagnostic imaging of pulmonary embolism (PE). J Nucl Med 2009; 50:1035P

Heiba S, Kolker D, Kapoor K, Son H, Kostakoglu L, Savitch I, DaCosta M and Machac J. Does SPECT/CT use provide incremental value to dual isotope imaging of diabetic foot? J Nucl Med 2009; 50:87P

Heiba S, Stock J, Khan S, Kostakoglu L, Savitch I and Machac J. Potential usefulness of SPECT/CT in distinguishing scar from acute pyelonephritis (AP) in renal cortical DMSA imaging: Preliminary data. J Nucl Med 2009; 50:558P

Son H, Kositwattanarerk A, Prasad-Hayes M, Heiba S, Machac J and Kostakoglu L. PET/CT evaluation of recurrence of various gynecological malignancies in the post-therapy setting. J Nucl Med 2009; 50:1100P

Jiang M, Machac J, Heiba S, Zhang Z, Knesaurek K, Weintraub J, Nowakowski S, Stangl A and Kim E. Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin (MAA) on hepatic perfusion imaging studies (HPI) and impact on Yttrium-90 (Y-90) microsphere therapy. J Nucl Med 2009; 50:214P

Son H, Kositwattanarerk A, Prasad-Hayes M, Heiba S, Machac J and Kostakoglu L. PET/CT evaluation of cervical cancer at staging and restaging. J Nucl Med 2009; 50:1099P

Kositwattanarerk A, Son H, Genden E, Jiang M, Machac J, Heiba S, Peter Som P and Kostakoglu L. PET/CT findings in patients with laryngeal cancer (LC) after therapy. J Nucl Med 2009; 50:1056P

Kositwattanarerk A, Son H, Genden E, Jiang M, Machac J, Heiba S, Som P and Kostakoglu L. PET/CT findings in patients with oropharyngeal cancer (OC) after therapy. J Nucl Med 2009; 50:1054P

17

Moroni E, Chin C, Simpson W, Kim J, Roayaie S, Heiba S, Machac J, and Kostakoglu L. Integrating FDG PET/CT interpretation with high dose contrast enhanced CT increases restaging accuracy of bile duct carcinomas. J Nucl Med 2008; 49: 58P.

Rangaswamy B, Fatterpekar G, Kim J, Som P, Genden E, Machac J, Heiba S, and Kostakoglu L. Combined interpretation of FDG-PET/CT and contrast enhanced high dose CT increases accuracy of restaging in head and neck cancers. J Nucl Med 2008; 49: 114P.

Heiba S, Kolker D, Mocherla B, Rangaswamy B, Kostakoglu L, and Machac J. Can dual isotope SPECT/CT scan be a gold imaging standard for diabetic foot evaluation? J Nucl Med 2008; 49: 134P.

Machac J, Heiba S, Zhang Z, Weintraub J, Nowakowski F, Stangl A, Schwartz M, and Warner R. Value of planar and SPECT/CT Tc-99m MAA liver perfusion imaging in planning of yttrium-90 Sir Sphere therapy of tumors of the liver. J Nucl Med 2008; 49: 144P.

Serafini A, Heiba S, Tumeh S, and Jacobson A. Influence of SPECT on interpretation of 123I-mIBG scintigraphy in patients with known or suspected pheochromocytoma and neuroblastoma. J Nucl Med 2008; 49: 239P.

Heiba S, Son H, Kostakoglu L, and Machac J. The incremental value of pinhole thyroid gland imaging to dual phase sestamibi pinhole & SPECT/CT imaging in evaluating primary hyperparathyroidism patients. J Nucl Med 2008; 49: 243P.

Knesaurek K, Kolker D, Vatti S, Machac J, Muzinic M, DaCosta M, Zhang Z, Mocherla B, and Heiba S. Accurate fusion of In-111 WBC SPECT/CT and MRI in diabetic foot evaluations using CT/MRI correlation. J Nucl Med 2008; 49: 264P.

Machac J, Heiba S, Zhang Z, Weintraub J, Nowakowski F, Stangl A, Schwartz M, and Warner R. Prediction of yttrium-90 Sir Sphere deposition by Tc-99m MAA SPECT/CT liver perfusion imaging. J Nucl Med 2008; 49: 323P.

Moroni E, Chin C, Simpson W, Kim J, Machac J, Heiba S, Sung M, and Kostakoglu L. The addition of contrast enhanced helical CT information to FDG PET/CT data enhances tumor detection rate in metastatic colorectal cancer. J Nucl Med 2008; 49: 346P.

Moroni E, Chin C, Simpson W, Kim J, Heiba S, Machac J, and Kostakoglu L. The incremental value of high dose contrast enhanced CT with dual phase helical CT to FDG PET/CT recurrent pancreatic carcinoma. J Nucl Med 2008; 49: 349P.

18

Heiba SI, Kolker D, Mocherla BR, Rangaswamy B, Kostakoglu L, Machac J. Optimized diabetic foot evaluation by a novel dual bone scan & In-111 leukocyte SPECT/CT imaging protocol: Preliminary data. J Nucl Med 2007;48:63P.

Heiba SI, Rangaswamy B, Kolker D, Kostakoglu L, Machac J. The diagnostic confidence of SPECT & SPECT/CT in Indium-111 leukocyte scintigraphy. J Nucl Med 2007;48:63P.

S. Heiba, B. R. Mocherla, L. Kostakoglu and J. Machac. The value of hybrid SPECT/CT in the bone scan evaluation of patients with back pain. J Nucl Med 2007;48:122P

L. Kostakoglu, B. Mocherla, B. Roman, P. Som, J. Kim, J. Kao, S. Packer, J. Machac, S. Sohn, S. Heiba and E. Genden.A different reading scale can increase specificity of PET/CT imaging in head and neck squamous cell carcinoma (HNSCC). J Nucl Med 2007;48:31P

L. Kostakoglu, S. Kim, E. Scigliano, P. Som, O. Keren, C. Grosskreutz, E. Genden, J. Machac, S. Heiba and L. Isola. Characteristics of patients with false positive FDG-PET findings after high dose therapy and autologous stem cell transplantation (HDT/ASCT). J Nucl Med 2007;48:183P

A. C. Riegel, A. M. Berson, S. Destian, T. Ng*, L. B. Tena, R. J. Mitnick, N. Stein, S. Heiba. Variability of Gross Tumor Volume Delineation in Head-and-neck Cancer Using PET/CT Fusion, Part II: The Impact of a Contouring Protocol. I J Radiation Oncology 2006;66:S660.

SI Heiba, I. Castellon, J. A. Katzel, R. Milardovic, E. Altinyay, B. Raphael, HM Abdel-Dayem and J. Coppola. Can the additional evaluation of post ischemic myocardial stunning amount in stress myocardial perfusion imaging further enhance the risk assessment of coronary disease patients? J Nucl Med 2006;47:203P.

SI Heiba, B. Raphael, I. Castellon, E. Altinyay, N. Sandella, H. M. Abdel-Dayem and G. Rosen. PET/CT fusion error due to urinary bladder filling changes: Simple correction with a repeat section imaging. J Nucl Med 2006;47:235P.

SI Heiba, I. Castellon, J. Vecchio, P. Bukberg, V. Yen, E. Altinyay, B. Raphael, HM Abdel-Dayem and I. Young1. Whole body scan post I-131 thyroid carcinoma ablation therapy: Overlap of findings between early and delayed imaging. J Nucl Med 2006;47:331P.

B. Raphael, M. E. Altinyay, I. Castellon, E. Piperkova, D. Kim, R. Libes, S. I. Heiba and H. M. Abdel-Dayem. Clinical impact of intravenous contrast enhanced diagnostic CT scan in patients with neoplastic disease in comparison with PET/CT imaging. J Nucl Med 2006;47:222P

19

Heiba SI, Katzel JA, Altinyay E, Milarodovic R, Castellon I, Raphael B, Abdel-Dayem HA, Coppola J. Optimized risk assessment of coronary disease patients by additional evaluation of post ischemic myocardial stunning amount in stress perfusion imaging. J Nucl Cardiol 2005;12:S107.

Heiba SI, Castellon I, Raphael B, Altinyay E, Abdel-Dayem HA, Coppola J, Elmquist T, and Mazzara J. The functional changes during low dose dobutamine induced left ventricular cavity constriction in gated SPECT imaging and correlation with thallium-201 myocardial uptake. J Nucl Cardiol 2005;12:S116.

Heiba SI, Castellon I, Vecchio J, Altinyay E, Bukberg P, Yen V, Abdel-Dayem HA and Young I. Whole body scan post I-131 thyroid carcinoma ablation therapy: early versus delayed imaging. J Nucl Med 2005;46:131P.

Heiba SI, Raphael B, Castellon I, Sandella N, Berson AM, Rosen G, Abdel-Dayem HM and Macdonald JS. PET/CT fusion error due to urinary bladder filling changes: exaggeration by the oral contrast fluid load. J Nucl Med 2005;46:413P.

Altinyay ME, Tena LB, Finger PT, Castellon I, Raphael B, Heiba SI, Abdel-Dayem HM. PET/CT experience in choroidal melanoma. J Nucl Med 2005;46:47P.

Heiba SI, Yee G, Coppola J, Elmquist T, Braff R, Youssef I, Ambrose JA, Abdel-Dayem HM. Optimal viability evaluation by a simplified rest redistribution thallium-201 and contractility assessment with low dose dobutamine combined protocol. J Nucl Cardiol 2004;11:S36.

Heiba SI, Youssef I, Elmquist T, Coppola J, Klapholz M, Infantino M, Braff R, Abdel-Dayem HM and Ambrose JA. Quantitative assessment of regional myocardial thickening in various stress myocardial perfusion patterns. J Nucl Med 2004;45:233P.

Heiba SI, Aiyer RK, Yee G, Coppola J, Elmquist T, Braff R, Youssef I, Ambrose JA and Abdel-Dayem HM. Combined rest redistribution SPECT thallium-201 and low dose dobutamine contractility assessment: a simple and effective myocardial viability protocol. J Nucl Med 2004;45:234P.

Youssef IM, Aiyer R, Quimbo RD, Heiba S, Axelrod D, Seigel B, Bernick S, Mills C, Abdel-Dayem HM. Incidence of non sentinel lymph node involvement in breast cancer in the presence of micro or macro metastasis on the sentinel node. J Nucl Med 2004;45:146P.

Youssef IM, Aiyer R, Quimbo RD, Heiba S, Axelrod D, Seigel B, Mills C, Bernick S, Abdel-Dayem HM. Factors contributing to non-visualization of sentinel lymph node in breast cancer lymphoscintigraphy. J Nucl Med 2004;45:357P.

20

Heiba SI, El-Zeftawy H, Ambrose JA & Abdel-Dayem HA. Combined rest-redistribution SPECT thallium-201 and low dose dobutamine myocardial viability assessment in a simple new protocol. J Nucl Cardiol 2003;10:S12.

Heiba SI, Youssef I, El-Zeftawy H, Ambrose JA & Abdel-Dayem HA. Quantitative regional myocardial thickening analysis in the different stress myocardial perfusion patterns. J Nucl Cardiol 2003;10:S12.

Heiba SI, Bernaski EJ, Morlote M, Mirzaitehrane M, Dakhel M, Gould R, Ambrose JA, Abdel-Dayem HM. The value of Low Dose Dobutamine addition to routine dual isotope gated SPECT myocardial imaging: A simple and useful new protocol. J Nucl Cardiol 2002;9:S16.

Heiba SI, Prakash AM, Dakhel M, Kaya GC, El-Zeftawy H, Ambrose JA, Abdel-Dayem HA. The diagnostic value of transient post-ischemic stunning in gated SPECT myocardial perfusion. J Nucl Cardiol 2002;9:S20.

Heiba SI, Dakhel M, Kaya GC, Abdel-Dayem HA. Is transient myocardial stunning in gated SPECT thallium-201 myocardial imaging affected by the method of stress used or the severity of ischemia? J Nucl Cardiol 2002;9:S7.

Abdel-Dayem HM, Sadek S, Heiba S, Steinmetz N, Cho J, Cook W, Klein P. Tc-99m rh-Annexin V for imaging apoptotic cells: clinical experience. World J Nucl Med 2002;1(2):S99.

Jana S, Dakhel M, Kumar R, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Mills C, Abdel-Dayem HM. Sentinel node localization in breast cancer: evaluation of controversies. World J Nucl Med 2002;1(2):S116-117.

Jana S, Young I, Bukberg P, Luo JQ, Dakhel M, Heiba S, El-Zeftawy H, Abdel-Dayem HM. Comparison of 24 hrs total body radio-iodine retention for hypothyroid versus Thyrogen stimulated whole body surveillance scan. World J Nucl Med 2002;1(2):S38.

Jana S, Kumar R, Heiba S, Dakhel M, Axelrod D, Seigel B, Bernik S, Mills C, Abdel-Dayem HM. Do we have to revise inclusion criteria for sentinel node localization in breast cancer? Eur J Nucl Med 2002;29:S131.

El-Zeftawy H, Dakhel M, Heiba S, Caruana S, Abdel-Dayem HM. Evaluation of F-18 FDG dual head coincidence imaging in diagnosis of recurrent head and neck tumors. Eur J Nucl Med 2002;29:S271.

Dakhel M, Aladdin MM, El-Zeftawy H, Perone R, Heiba S, Abdel-Dayem HM. Impact of hybrid F-18 FDG PET scan on initial staging of various types of malignant lymphoma compared with CT scan. Eur J Nucl Med 2002;29:S272.

21

Heiba SI, Prakash AM, Dakhel M, Kaya GC, El-Zeftawy H, Ambrose JA, Abdel-Dayem HA. Does the recognition of transient post-ischemic stunning in gated SPECT myocardial perfusion imaging have a diagnostic value in patients with CAD? J Nucl Med 2002;43:96P.

Heiba SI, Bernaski EJ, Morlote M, Mirzaitehrane M, Dakhel M, Gould R, Ambrose JA, Abdel-Dayem HM. The value of Low Dose Dobutamine addition in a simple modification of routine dual isotope gated SPECT imaging protocol. J Nucl Med 2002;43:94P.

Heiba SI, Dakhel M, Kaya GC, Abdel-Dayem HA. Transient myocardial stunning in gated SPECT thallium-201 myocardial imaging: comparison between methods of stress testing. J Nucl Med 2002;43:96P.

Jana S, Dakhel M, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Bernik S, Mills C, Wallack M, Luo J, Abdel-Dayem HM. Is axillary dissection mandatory for patients of breast cancer with tumor size 4 cm or more? J Nucl Med 2002;43:290P.

Jana S, Kumar R, Dakhel M, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Bernik S, Mills C, Wallack M, Luo J, Abdel-Dayem HM. Multifocal/multicenteric breast carcinoma: is it an absolute contraindication for sentinel node localization? J Nucl Med 2002;43:20P.

El-Zeftaway H, LaBombardi V, Dakhel M, Heiba S, Abdel-Dayem H. Evaluation of F-18 FDG PET imaging in diagnosis of disseminated mycobacterium avium complex in AIDS patients. J Nucl Med 2002;43:127P.

Dakhel M, Sharabi A, Gillooley J, Correte L, Bonfils E, El-Zeftawy H, Perone R, Heiba S, Abdel-Dayem HM. Comparison of F-18 FDG Hybrid PET and CT in mediastinal staging of non-small cell lung cancer. J Nucl Med 2002;43:151P.

Santiago J, Jana S, Heiba SI, Mirzaitehrane M, Dede F and Abdel-Dayem HM. Transient ischemic stunning of the myocardium in stress Tl-201 gated SPECT myocardial imaging: Segmental analysis of myocardial perfusion, wall motion and wall thickening changes. J Nucl Med 2001;42:94P.

Heiba SI, Mirzaitehrane M, Gould R, Dakhel M, Baskaran S, Morlote M, Bernaski EJ, Ambrose J and Abdel-Dayem HA. Myocardial contractility evaluation with low dose dobutamine during routine dual isotope gated SPECT pharmacological stress studies: a simple and effective new imaging protocol. J Nucl Med 2001;42:6P.

Jana S, Dakhel M, Axelrod D, Seigel B, Baskaran S, Mills C, Heiba S, Wallack M, Luo J, Sadek S, Abdel-Dayem HA. Does excisional biopsy of breast mass affect the negative predictive value, accuracy or success rate of sentinel node

22

localization? J Nucl Med 2001;42:154P.

Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Dede F and Abdel-Dayem HA. Transient ischemic myocardial stunning in stress gated SPECT thallium-201 imaging: Methods of assessment and effect on systolic LV function J Nucl Cardiol 2001;8:S76.

Mirzaitehrane M, Heiba SI, Dede F, Santiago J, Jana S and Abdel-Dayem HA. The feasibility of automated quantitative analysis of the gated SPECT thallium-201 myocardial imaging in detection of post ischemic myocardial stunning. J Nucl Cardiol 2001;8:S40.

Santiago J, Jana S, Heiba SI, Mirzaitehrane M, Dede F and Abdel-Dayem HM. Myocardial stunning evaluation in stress thallium-201 gated SPECT myocardial imaging: Segmental analysis of myocardial perfusion, wall motion and wall thickening changes. J Nucl Cardiol 2001;8:S9.

S Jana, M Dakhel, D Axelrod, B Siegel, S Bhaskaran, C Mills, S Heiba, S Salem, M Wallack, J Luo and H M Abdel-Dayem: Affect of Excisional of Breast Mass on Negative Predictive Value, Accuracy or Success Rate of Sentinel Node localization. Eur J Nucl Med 2001;28:1124.

Santiago J, Jana S, Salem S, Heiba S and Abdel-Dayem HM. The use of Fluorine-18-Fluordeoxyglucose positron emission tomography (F-18 FDG PET) in the follow-up of non-Hodgkin’s lymphoma in patients with acquired immune deficiency syndrome (AIDS). Eur J Nucl Med 2000;27:1160.

Heiba SI, Salem S, Jana S, Santiago J and Abdel-Dayem HM. The utility of F-18 FDG imaging in the routine evaluation of patients with sarcoidosis: preliminary report. Clin Nucl Med 2000;25:327.

Jana S, Santiago JF, Young I, Yen V, Heiba S, Salem S, Sethi Y, Luo J, Bukberg P, Sadek S and Abdel-Dayem HM. Effect of Thyrogen administration on total body radioiodine clearance in the work-up of thyroid cancer patients with normal kidney and liver functions. J Nucl Med 2000;41:310P.

Jana S, Axelrod D, Siegel B, Santiago JF, Mills C, Heiba S, Salem S, Wallack K, Sethi Y, Luo J and Abdel-Dayem HM. Correlation of sentinel node localization using blue dye and radiocolloid methods in T1 & T2 breast cancer with histopathological findings: Assessment of accuracy and negative predictive value according to tumor size. J Nucl Med 2000;41:281P.

Jana S, Santiago J, Young I, Yen V, Buckberg P, Luo J, Heiba S, Salem S, Sadek S and Abdel-Dayem HM. Comparison of I-123 total body retention in disease free cancer thyroid patients with and without Thyrogen injection. Eur J Nucl Med 2000;27:931.

23

Jana S, Axelrod D, Siegel B, Santiago J, Mills C, Heiba S, Wallack M, Salem S, Sadek S, Abdel-Dayem HM. Evaluation of success rate, accuracy and negative predictive value of sentinel node localization in breast cancer using blue dye and radiocolloid methods with histopathological correlation. Eur J Nucl Med 2000;27:975.

Tailji S, Abdella N, Mooro M, Newman D, Mohamed A, Loutfi I, Yacoub TY, Al-Bunni A, Al-Za’sbi K, Heiba S, Elgazzar A. 99mTc MDP and In-111 labeled leucocytes scintigraphy in diabetic foot: Optimal evaluation of simultaneous acquisition. J Nucl Med 2000;41:327P.

Santiago J, Jana S, Salem S, Heiba S and Abdel-Dayem. Comparison between F-18 FDG PET scans in patients with AIDS and non-Hodgkin’s lymphoma: A preliminary report. Clin Nucl Med 2000;25:327.

S Jana, J F Santiago, I Young, V Yen, P Buckberg, J Luo, S Heiba, S Salem, S Sadek and H M Abdel-Dayem: Rapid Clearance of I-123 in Cancer Thyroid Patients following Thyrogen injections, Compared to Hypothyroid patients off Thyroid replacement. VII Asia and Oceania Congress of Nuclear Medicine and Biology & IV International Congress of Nuclear Oncology, Istanbul, Turkey, Oct 1-5, 2000.

S Jana, D Axelrod, B Siegel, J Santiago, C Mills, S Heiba, S Salem, M Wallack, Y Sethi, J Luo and H M Abdel-Dayem: Histopathological Correlation of Sentinel Node Localization using blue dye and radio colloid methods in early Breast Cancer. VII Asia and Oceania Congress of Nuclear Medicine and Biology & IV International Congress of Nuclear Oncology, Istanbul, Turkey, Oct 1-5, 2000.

Heiba SI, Higazy E, Elgazzar AH. Right lateral Tc-99m Sestamibi myocardial perfusion SPECT: Diagnostic accuracy of quantitation. Eur J Nucl Med 1999;26:1045.

Heiba SI, Loutfi I, Al-Za’abi K, El-Doza B and Elgazzar AH. Effect of observer variation in interpreting ventilation perfusion lung scan on patient management. Eur J Nucl Med 1999;26:1206.

Higazi E, Kalaoui M, Alnakib B, Heiba S, Loutfi I, Patty S, Mohammed A, Gopinath S, Matthew M, Hussein A, Samy M and Elgazzar A. Value of teeth brushing before obtaining liquid C-14 urea breath test. Eur J Nucl Med 1999;26:1203.

Heiba SI, Loutfi I, Al-Za’abi K, El-Doza B and Elgazzar AH. The significance of observer variation in ventilation/perfusion scan interpretation. J Nucl Med 1999;40:196P.

24

Heiba SI, Higazy E and Elgazzar AH. Diagnostic accuracy of quantitative analysis in right lateral Tc-99m MIBI myocardial SPECT. J Nucl Med 1999;40:173P.

Heiba SI, Loutfi I, Al-Za’abi Z and Elgazzar AH. Interobserver variability in the assessment of perfusion defect size: effect on lung scan interpretation. Eur J Nucl Med 1998;25:891.

Baqer M, Muhassein S, Al-Tailji S, Khadada M, Higazi E, Heiba S and Elgazzar AH. Role of nuclear medicine physicians in post ventilation/perfusion (V/Q) scan probability of pulmonary embolism. Eur J Nucl Med 1998;25:1094.

Heiba SI, Ziada G, Higazy E and Saleh M. Pitfall of Tc-99m Tetrofosmin Lung Uptake Assessment and How to Avoid it: Comparison with Thallium-201 and Tc-99m Sestamibi Myocardial SPECT Studies. Eur J Nucl Med 1997;24:971.

Heiba SI, Higazy EE, Sayed ME, Khalaf AI, Saleh Z, Naeem M, Salman HS, Borously S and Hayat NJ. Preliminary analysis of myocardial Tc-99m sestamibi SPECT vs. right lateral imaging: direct comparison of diagnostic accuracy with coronary arteriography. J Nucl Med 1996;37:48P.

Higazi E, Sayed M, Heiba S, Khalaf A, Salman H, Saleh Z, Naeem M, Borously S, Hayat N. Validation of Lateral Position Quantitative Tc-99m Sestamibi SPECT Imaging with Coronary Arteriography. Eur J Nucl Med 1996;23:1259.

Heiba SI, Ziada G, Higazy E and Saleh M. Lung uptake in normal Tc-99m Tetrofosmin myocardial SPECT: Subdivision and comparison with Tc-99m sestamibi. 6th Asia and Oceania Congress of Nuclear Medicine and Biology, Kyoto, Japan, 30 Sept. - 4 Oct. 1996.

Heiba SI, Jacobson AF, Shattuc S, Cerqueira MD. Additive value of radionuclideventriculography to dipyridamole thallium imaging for risk stratification prior to vascular surgery. J Nucl Med 1993;34:74P.

Sfakianakis GN, Heiba S, Lockhart J, Lynn C, Zilleruelo G, Abitol C, Strauss J, Politano V. Diuretic renography with early injection of furosemide: a reliable and cost effective approach. J Nucl Med 1998;30:841.

Heiba S, Serafini A, Reddy R, Jeffers L. Role of gallium scintigraphy in the follow-up of patients operated on for hepatocellular carcinoma. J Nucl Med 1987; 28:1792.

Ganz WI, Heiba S, Ganz S, Serafini A. Prognostic role of liver spleen scan in AIDS patients. J Nucl Med 1987;28:1792.

25

Ganz WI, Ganz SS, Heiba S, Levina T, Serafini A. Diagnostic pattern of gallium-67 lung uptake in AIDS patients. J Nucl Med 1987;28:1792.

ORAL PRESENTATIONS BY INVITATION

The early distinction between diabetic foot osteomyelitis and Charcot joint during initial phase leukocyte (WBC)/bone scan dual isotope SPECT/CT imaging. June 8-12, 2013 Vancouver, BC, CANADA.

Impact of dual isotope SPECT/CT on hospitalized patients with suspected diabetic foot infection: Comparison to conventional imaging. Society of Nuclear Medicine Annual Meeting, Miami, FL, June 9-13, 2012.

The beneficial influence of dual isotope SPECT/CT use on management of patients with suspected diabetic foot infection. Society of Nuclear Medicine Annual Meeting, San Antonio, TX, June 4-8, 2011. Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies with & without SPECT/CT for parathyroid adenoma localization. Society of Nuclear Medicine Annual Meeting, San Antonio, TX, June 4-8, 2011.

Advantage of SPECT/CT use in DMSA renal imaging for work-up of suspected acute pyelonephritis. Society of Nuclear Medicine Annual Meeting, Salt Lake City, UT, June 6-9, 2010.

The continuing management of diabetic foot infection: Impact of follow-up with dual tracer SPECT/CT. Society of Nuclear Medicine Annual Meeting, Salt Lake City, UT, June 6-9, 2010.

Does SPECT/CT use provide incremental value to dual isotope imaging of diabetic foot? Society of Nuclear Medicine Annual Meeting, Toronto, Ontario, Canada, June 13-17, 2009.

Potential usefulness of SPECT/CT in distinguishing scar from acute pyelonephritis (AP) in renal cortical DMSA imaging: Preliminary data. Society of Nuclear Medicine Annual Meeting, New Orleans, LA, June 14-18, 2008.

Can dual isotope SPECT/CT scan be a gold imaging standard for diabetic foot evaluation? Society of Nuclear Medicine Annual Meeting, New Orleans, LA, June 14-18, 2008.

Optimized diabetic foot evaluation by a novel dual bone scan & In-111 leukocyte SPECT/CT imaging protocol: Preliminary data. Society of Nuclear Medicine Annual Meeting, Washington, D.C., June 3-7, 2007.

26

The value of hybrid SPECT/CT in the bone scan evaluation of patients with back pain. Society of Nuclear Medicine Annual Meeting, San Diego, CA, June 3-7, 2006.

PET/CT fusion error due to urinary bladder filling changes: Simple correction with a repeat section imaging. Society of Nuclear Medicine Annual Meeting, San Diego, CA, June 3-7, 2006.

Whole body scan post I-131 thyroid carcinoma ablation therapy: early versus delayed imaging. Society of Nuclear Medicine Annual Meeting, Toronto, Canada, June18-23, 2005

Incidence of non sentinel lymph node involvement in breast cancer in the presence of micro or macro metastasis on the sentinel node. Society of Nuclear Medicine Annual Meeting, Philadelphia, PA, June19-23, 2004

Does the recognition of transient post-ischemic stunning in gated SPECT myocardial perfusion imaging have a diagnostic value in patients with CAD? Society of Nuclear Medicine Annual Meeting, Los Angeles, CA, June15-19, 2002.

The value of Low Dose Dobutamine addition in a simple modification of routine dual isotope gated SPECT imaging protocol. Society of Nuclear Medicine Annual Meeting, Los Angeles, CA, June15-19, 2002.

Transient myocardial stunning in gated SPECT thallium-201 myocardial imaging: comparison between methods of stress testing. Society of Nuclear Medicine Annual Meeting, Los Angeles, CA, June15-19, 2002.

Myocardial contractility evaluation with low dose dobutamine during routine dual isotope gated SPECT pharmacological stress studies: a simple and effective new imaging protocol. Society of Nuclear Medicine Annual Meeting, Toronto, Ontario, Canada, June 23-27, 2001

Transient ischemic stunning of the myocardium in stress Tl-201 gated SPECT myocardial imaging: Segmental analysis of myocardial perfusion, wall motion and wall thickening changes. Society of Nuclear Medicine Annual Meeting, Toronto, Ontario, Canada, June 23-27, 2001.

Transient ischemic myocardial stunning in stress gated SPECT thallium-201 imaging: Methods of assessment and effect on systolic LV function. 5TH International Conference of Nuclear Cardiology, Vienna, Austria, May 2-5, 2001

The feasibility of automated quantitative analysis of the gated SPECT thallium-201 myocardial imaging in detection of post ischemic myocardial stunning. 5TH International Conference of Nuclear Cardiology, Vienna, Austria, May 2-5, 2001.

27

Inter-observer variability in the assessment of perfusion defect size: effect on lung scans interpretation. Joint EANM and WFNM&B Congress August 30 - Sept. 4, 1998, Berlin, Germany

“Tc-99m Sestamibi Myocardial SPECT Supine Vs Right Lateral Imaging: Direct Comparison of Diagnostic Accuracy with Coronary Arteriography”. Annual Meeting, Society of Nuclear Medicine, Denver, CO, June 3-5, 1996

“Pharmacological stress: A substitute for treadmill exercise for diagnosing myocardial ischemia”. Current concepts in drug therapy CME course, University of Washington School of Medicine, Seattle, WA. Nov. 4-5, 1993.

“Additive value of radionuclide ventriculography to dipyridamole thallium imaging for risk stratification prior to vascular surgery”. Annual Meeting, Society of Nuclear Medicine-Toronto, Canada. June 8-11, 1993.

Journal Editor

2012 International Journal of BioMed Research, India

JOURNAL REVIEWER

2014 European Journal of Hematology, Germany2007-2011 Journal of Urology, USA2009 Imaging in Medicine, USA2005 Lancet, UK2000 Journal of Nuclear Medicine, USA

CONTRIBUTION IN CD ROM (EDUCATIONAL)

Multifunctional Gamma Camera Coincidence Imaging: Current Status and Evaluation of Clinical Results: by H Abdel-Dayem MD, J Luo PhD, S Sadek PhD, S Salem MD, J Santiago MD, S Jana MD, Hossam El-Zeftawy MD, and S Heiba MD. -- This CD was made to train the Nuclear Medicine Technologist and physicians for Dual Head Coincidence Imaging.

PERSONAL DATA

Sex Male

28

Born January 26, 1953

Citizenship: USA

Marital Status Married and have 2 children

29

curriculum vitae revised 9/31/98parathyroid.surgerymountsinai.org/wp-content/uploads/si… · web...

Documents